Who
Nikolay Savchuk
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Traws Pharma; President and COO, Lomond Therapeutics Holdings.
In numbers
- Trades disclosed
- 26
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Apr 2024
- Last trade
- 9 Jul 2026
- Last filed
- 15 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jul 2026filed 15 Jul 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —93,000 at $0.00 | filing |
| 9 Jul 2026filed 15 Jul 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —93,000 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —96,899 at $0.00 | filing |
| 8 Mar 2026filed 10 Mar 2026 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —96,899 at $0.00 | filing |
| 12 Dec 2025filed 16 Dec 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,676 at $0.00 | filing |
| 12 Dec 2025filed 16 Dec 2025 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Code A | —16,419 at $0.00 | filing |
| 12 Oct 2025filed 15 Oct 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,435 at $0.00 | filing |
| 2 Apr 2025filed 8 Apr 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code J | —2,263.75 at $0.00 | filing |
| 2 Apr 2025filed 8 Apr 2025 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Code J | —605,531 | filing |
| 29 Dec 2024filed 27 Jan 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code P | —96,348 | filing |
| 29 Dec 2024filed 27 Jan 2025 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code P | —96,348 | filing |
| 1 Nov 2024filed 5 Nov 2024 | Lomond Therapeutics Holdingsoption or derivative | SEC FORM 4 Code A | —1,258,000 at $0.00 | filing |
| 1 Nov 2024filed 5 Nov 2024 | Lomond Therapeutics Holdingsoption or derivative | SEC FORM 4 Code C | —539,062 at $0.00 | filing |
| 1 Nov 2024filed 5 Nov 2024 | Lomond Therapeutics Holdingsoption or derivative | SEC FORM 4 Code C | —694,444 at $0.00 | filing |
| 1 Nov 2024filed 5 Nov 2024 | Lomond Therapeutics Holdings | SEC FORM 4 Code C | $1.7M539,062 at $3.20 | filing |
| 1 Nov 2024filed 5 Nov 2024 | Lomond Therapeutics Holdings | SEC FORM 4 Code C | $2.5M694,444 at $3.60 | filing |
| 1 Nov 2024filed 5 Nov 2024 | Lomond Therapeutics Holdings | SEC FORM 4 Code A | $5.8M1,443,750 at $4.00 | filing |
| 1 Apr 2024filed 7 Aug 2024 | TRAW Traws PharmaBiotechnology | SEC FORM 4 Code A | —67,500 | filing |
| 1 Apr 2024filed 3 Apr 2024 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,802,890 | filing |
| 1 Apr 2024filed 3 Apr 2024 | TRAW Traws Pharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —194.62 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.